Cimetidine 200mg Tablet Franchise in Ahmedabad

Acid Reducer Tablet Supplier in Bangalore

H2 Receptor Antagonist Tablet Distributor in Hyderabad

Gastric Health Tablet Franchise Opportunity in Jaipur

Cimetidine 200mg Tablet Stockist in Mumbai
Cimetidine Tablet Export & Manufacturing in Chandigarh

Home/Products /cimetidine-200mg-tablet

Cimedose 200 Tablet

Composition : Cimetidine (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Cimedose 200 Tablet contains Cimetidine 200mg, a well-established H2 receptor antagonist used for the management of gastric acid-related conditions such as acid reflux, heartburn, peptic ulcers, and gastroesophageal reflux disease (GERD). It works by reducing excess stomach acid production, providing relief from discomfort and promoting healing of ulcerated tissues.

The formulation ensures consistent absorption and prolonged action, making it effective for both acute and chronic gastric conditions. Cimetidine is preferred by physicians for its predictable results and safety profile in adult patients requiring acid suppression therapy.

For distributors and resellers, Cimedose 200 Tablet is a high-demand gastrointestinal product, routinely prescribed in gastroenterology clinics, hospitals, and general medicine practices. Its broad therapeutic application ensures continuous demand and recurring orders throughout the year.

Adding Cimedose 200 Tablet to your portfolio strengthens your gastrointestinal therapy and hospital-care segment, offering opportunities for bulk institutional supply, private clinic distribution, pharmacy chains, export markets, and third-party manufacturing. Its essential role in acid-related disorder management makes it a profitable and strategically important product for pharmaceutical distributors.


Read More

About the Product

Cimedose 200 Tablet contains Cimetidine 200mg, a well-established H2 receptor antagonist used for the management of gastric acid-related conditions such as acid reflux, heartburn, peptic ulcers, and gastroesophageal reflux disease (GERD). It works by reducing excess stomach acid production, providing relief from discomfort and promoting healing of ulcerated tissues.

The formulation ensures consistent absorption and prolonged action, making it effective for both acute and chronic gastric conditions. Cimetidine is preferred by physicians for its predictable results and safety profile in adult patients requiring acid suppression therapy.

For distributors and resellers, Cimedose 200 Tablet is a high-demand gastrointestinal product, routinely prescribed in gastroenterology clinics, hospitals, and general medicine practices. Its broad therapeutic application ensures continuous demand and recurring orders throughout the year.

Adding Cimedose 200 Tablet to your portfolio strengthens your gastrointestinal therapy and hospital-care segment, offering opportunities for bulk institutional supply, private clinic distribution, pharmacy chains, export markets, and third-party manufacturing. Its essential role in acid-related disorder management makes it a profitable and strategically important product for pharmaceutical distributors.


Some patients may experience headache, dizziness, diarrhea, or mild fatigue. Rarely, allergic reactions, confusion, or liver enzyme changes may occur.

It is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, dyspepsia, and other acid-related disorders. It helps promote healing of ulcers, alleviate discomfort, and prevent recurrence of acid-related symptoms.

Use under medical supervision. Avoid in patients with known hypersensitivity to cimetidine or severe liver/kidney impairment. Take as prescribed and do not exceed recommended doses.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation